Severe Mycoplasma hominis infections in two renal transplant patients.
Systemic infections due to Mycoplasma hominis are rare and occur mainly in immunocompromised patients. Reported here are the cases of two renal transplant patients with peritonitis who did not respond to empirical antimicrobial treatment. Effective treatment with doxycycline was administered only after definitive identification of Mycoplasma hominis was achieved. For this identification, the new genetic amplification-sequencing method was invaluable.
Service des Maladies Infectieuses, Hôpitaux Universitaire de Genève, 1211 Genève 14, Switzerland. peter.rohner@hcuge.ch
P
P
Rohner
I
I
Schnyder
B
B
Ninet
J
J
Schrenzel
D
D
Lew
T
T
Ramla
J
J
Garbino
V
V
Jacomo
D000328:Adult; D000900:Anti-Bacterial Agents; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D016867:Immunocompromised Host; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology*; D008875:Middle Aged; D009175:Mycoplasma Infections / Q000175:diagnosis* / Q000188:drug therapy; D019535:Mycoplasma hominis / Q000302:isolation & purification*; D018570:Risk Assessment; D014181:Transplantation Immunology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents